Skip to main content
IMS Events Main banner
Back

    Hermann Einsele, MD, FRCP (he/him/his)

    Clinic Director
    Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
    Würzburg, Bayern, Germany

    Hermann Einsele, MD, FRCP, is Full Professor of Internal Medicine and has been Director of the Department of Internal Medicine II of the University Hospital Würzburg, Germany, since 2004.
    Following his medical training at the Universities of Tübingen, Manchester, and London, Hermann Einsele became a research fellow in the Department of Haematology, Oncology, Rheumatology, and Immunology at the University of Tübingen, Germany. Hermann Einsele was board certified in Internal Medicine in 1991 and in Haematology/Oncology in 1996. In 1999, he was promoted as an Associate Professor. He was Visiting Professor at the City of Hope Hospital, Duarte, CA and the Fred Hutchinson Cancer Research Center Seattle, USA.

    From 2011-2015 and since 2022 Hermann Einsele is Vice Dean of the Faculty of Medicine, and from 2015 -2021 Vice President of the University of Würzburg. Since 2018, he is chair of the scientific working group on immunotherapy for hematological malignancies of the European Hematology Association

    In 2003, he received the van Bekkum Award, the highest Annual European award for research in the field of stem cell transplantation. In 2011, he was elected as an Honorary Fellow of the Royal College of Pathologists (London) and in 2012 Nobel Lecturer Stem Cell Biology/ Transplantation, Nobel Forum Karolinska Institute. Since 2014, he was elected as a member of the Academy of Sciences and Literature, Mainz and as an ISI “Highly Cited Researcher” in the category Clinical Medicine since 2017. In 2022, Prof. Einsele received the Erasmus Hematology Award 2022 from the Erasmus University Medical Center, Rotterdam, Netherlands and the Bavarian Constitutional Medal. In 2023, he received the Emil von Behring Prize from the German Society for Transfusion Medicine and Immunohematology (DGTI).

    Hermann Einsele is expert in the field of multiple myeloma with focus on CAR T cells, bi-specific antibodies, adoptive immunotherapy and stem cell transplantation.

    Disclosure information not submitted.

    Presentation(s):